Projects

At the Lundin Family Brain Tumour Research Centre, our aim is to facilitate the exchange of ideas between clinicians and biologists, conduct cutting-edge translational and clinical research and promote individualized therapy for patients with brain tumours. 

Our priority is to advance brain cancer research by offering financial support for a minimum of five clinical studies through a competitive grant program. We are committed to both international and in-house clinical trials. They provide unparalleled opportunities for patients.

Currently, we are dedicated to advancing two priority projects, shaping the future of treatment. Learn more about these projects in translational research and the pioneering field of Flash radiotherapy. These exemplify the cutting-edge work undertaken at our Centre.

Translational cancer research  Flash radiotherapy Data

Our Centre aims to achieve the following strategies that contribute to transformative brain tumour research:

• Strengthening collaborations between experts
  Brain tumour research requires collaboration between scientists, clinicians, and other healthcare professionals. Strong partnerships with experts in various fields, such as neurology, neurosurgery, radiology, neuropathology, genetics, and oncology, can lead to innovative ideas and the development of novel approaches to treating brain tumours. Engaging with international experts is also essential.
   
• Applying cutting-edge technologies
  Advanced technologies are necessary for studying the biology of tumours, diagnosing patients, and developing effective treatments. Researchers should stay updated with the latest advances in technology and apply them to their research. For example, using advanced imaging techniques, such as PET scans and MRI can provide valuable insights into the structure and function of brain tumours.
   
• Prioritizing patient-centred research
  This should focus on improving the quality of life for patients and their families. Researchers should engage with patients and caregivers to understand their needs, concerns, and experiences and formulate relevant questions that address their priorities.
   
• Embracing innovation
  To lead transformative brain tumour studies, researchers are open to innovation and experimentation. This involves thinking outside the box, taking calculated risks, and exploring new approaches to understanding and treating brain tumours. They also learn from setbacks and adapt their approaches accordingly.
   
• Securing long-term commitment
  Leading transformative brain tumour research requires significant resources, including funding. The long-term commitment of the Lundin Foundation ensures that the projects and collaboration are not only set up but also completed and adapted over the long term.